Department of Environmental and Occupational Health, University of South Florida College of Public Health, 13201 Bruce B. Downs Blvd., Tampa, FL 33612, USA.
Clin Toxicol (Phila). 2010 Feb;48(2):121-3. doi: 10.3109/15563650903476483.
Brevetoxin (PbTx), taken from the earlier species name Ptychodiscus brevis, is a red algae toxin. It has been associated with clinically observed bronchoconstriction in nonasthmatics. In asthmatics, similar exposures may produce severe transient effects, sometimes requiring emergency treatment, thus suggesting that asthmatics are more sensitive to this toxin. As such, we have investigated potential mechanisms in vitro.
Membrane potentials of in vitro airway smooth muscle (ASM) preparations were measured with a microelectrode before, during, and after the exposure to PbTx (0.01-1.2 microg/mL) in strip preparations (SPs) and cultured ASM reaggregate preparations. The latter preparation results in the disruption of normal peripheral nervous ASM associations through enzymatic dissociation of cells.
We observed an increased level of depolarization in asthmatic preparations at the same level of exposure. Exposure to PbTx produced concentration-dependent depolarization in both nonasthmatic and asthmatic in vitro SPs. In the former, responses did not occur in the presence of the blocking agents such as atropine or tetrodotoxin (TTX). In asthmatic SPs, atropine and TTX produced little effect, whereas verapamil blocked the PbTx-induced depolarization. The toxin was without effect in nonasthmatic cultured cells, whereas acetylcholine produced depolarization that was blocked in the presence of atropine, but not TTX or verapamil. In contrast, the toxin produced significant depolarization in cultured asthmatic ASM cells, which were unaffected by either atropine or TTX but were blocked by verapamil.
We propose that PbTx directly affects asthmatic ASM whereas the effect is neurally mediated in nonasthmatics.
Brevetoxin(PbTx),取自早期的物种名 Ptychodiscus brevis,是一种红藻毒素。它与非哮喘患者临床观察到的支气管收缩有关。在哮喘患者中,类似的暴露可能会产生严重的短暂影响,有时需要紧急治疗,这表明哮喘患者对这种毒素更敏感。因此,我们在体外研究了潜在的机制。
在条状(SP)和培养的气道平滑肌(ASM)再聚集制剂中,用微电极在暴露于 PbTx(0.01-1.2 微克/毫升)之前、期间和之后测量体外气道平滑肌(ASM)制剂的膜电位。后者的制剂通过细胞的酶解离破坏了正常的周围神经 ASM 关联。
我们观察到在相同暴露水平下,哮喘制剂的去极化水平升高。PbTx 暴露在非哮喘和哮喘体外 SP 中均产生浓度依赖性去极化。在前一种情况下,在阻断剂如阿托品或河豚毒素(TTX)存在的情况下,不会发生反应。在哮喘 SP 中,阿托品和 TTX 几乎没有效果,而维拉帕米则阻断了 PbTx 引起的去极化。该毒素对非哮喘培养细胞没有影响,而乙酰胆碱产生去极化,在阿托品存在下被阻断,但 TTX 或维拉帕米则不受影响。相比之下,毒素在培养的哮喘 ASM 细胞中产生显著的去极化,该细胞对阿托品或 TTX 均无反应,但被维拉帕米阻断。
我们提出 PbTx 直接影响哮喘 ASM,而在非哮喘患者中,这种影响是神经介导的。